Vending machine Naloxone Distribution for Your community (VENDY): Increasing reach and implementation of naloxone distribution
社区自动售货机纳洛酮配送 (VENDY):扩大纳洛酮配送的覆盖范围和实施
基本信息
- 批准号:10664040
- 负责人:
- 金额:$ 14.73万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-15 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAdoptionAdverse eventAustraliaAwarenessCOVID-19 pandemicCommunitiesDataDevelopment PlansDisparityDissemination and ImplementationEffectivenessEnsureEpidemicEquityEuropeEvaluationEventEvidence based practiceEvidence based programFundingFutureGeographyGoalsHarm ReductionHealth systemHomeIndividualInterventionInterviewLifeLocationMaintenanceMentorsModelingNaloxoneNational Institute of Drug AbuseNeedle-Exchange ProgramsOpioid AntagonistOutcomeOverdose reductionOverdose reversalPharmaceutical PreparationsPhysical environmentPoliciesPopulationPopulations at RiskPractical Robust Implementation and Sustainability ModelPrivacyPublic HealthQualitative EvaluationsReach, Effectiveness, Adoption, Implementation, and MaintenanceResearchResearch Project GrantsResource-limited settingRiskRuralRural CommunitySafetySecureServicesSocial EnvironmentSurveysTarget PopulationsTestingTrainingUnderserved PopulationUnited StatesUrban CommunityWorkbuilt environmentcareercareer developmentcostdesigneffective interventionevidence baseexperiencehigh riskimplementation barriersimplementation costimplementation strategyimprovedinnovationinterestlow socioeconomic statusmemberopioid epidemicopioid misuseopioid mortalityopioid overdoseopioid useopioid useroverdose deathpragmatic randomized trialpragmatic trialprogramsskillssubstance usetoolunderserved communityuptakeusabilityuser centered designyoung adult
项目摘要
PROJECT SUMMARY/ABSTRACT
There has been more than a 30% increase in opioid overdose deaths in the last year. Bystander access to
naloxone medication effectively reverses opioid overdose deaths with limited adverse events. However, current
naloxone distribution strategies are missing individuals at high risk of opioid overdose. Vending machines are
an innovative strategy shown to increase reach of harm reduction services in Europe. Young adults who
witnessed or experienced an opioid overdose expressed a desire for naloxone vending machines but identified
features of the built environment (including safety and location) as perceived factors contributing to use. There
is widespread interest in naloxone vending machines in the U.S. Yet, implementation challenges have slowed
down or limited adoption including navigating stakeholder approvals and identifying appropriate locations for
placement. The aim of this proposal is to study a community-initiated, stakeholder engaged adaptation of
naloxone distribution, VEnding machine Naloxone Distribution for Your community (VENDY), to increase the
reach of naloxone in underserved populations at-risk of opioid overdose. Study Aims include:
Aim 1: To refine the VENDY program in 3 underserved communities (2 urban and 1 rural) using an
iterative user centered design (UCD) implementation strategy and stakeholder engagement to increase
reach, implementation, and sustainability. We will use iterative usability and message testing to refine the
program with community members who misuse opioids. We will conduct surveys and qualitative interviews
with stakeholder to refine the UCD implementation strategy for future use.
Aim 2: Conduct a 6 month pilot assessment of the VENDY program in 2 urban and 1 rural community.
The pilot includes a midcourse adaptation and evaluation of reach, effectiveness, adoption, implementation
and maintenance (RE-AIM) outcomes.
Aim 3: Identify factors in the social and built environment contributing to reach and implementation of the
VENDY program using photovoice qualitative evaluations with organization implementers and community
members currently using opioids. Photovoice evaluations will occur in potential locations in Aim 1 to inform
VENDY placement and in the VENDY location in Aim 2 to inform stakeholder adaptations.
Community-based approaches such as VENDY are particularly important to reach opioid users not currently
engaged with health systems. To accomplish these aims, Dr. Wagner will pursue training in 1) user centered
design, an innovative implementation strategy, 2) conduct of pragmatic trials in diverse settings, and 3)
assessment of the built and social environment and its effect on reach and implementation. This mentored
research project and career development plan are designed to prepare Dr. Wagner to become a leader in the
adaptation of effective interventions addressing substance use to better reach underserved populations and to
produce sustainable implementation models.
项目摘要/摘要
去年,阿片类药物过量死亡增加了30%以上。旁观者访问
纳洛酮药物有效地逆转了不良事件有限的阿片类药物过量死亡。但是,当前
纳洛酮的分布策略是缺失阿片类药物过量风险的个体。自动售货机是
一种创新的策略,该策略显示出欧洲减少伤害服务的影响力。年轻人
目击或经历了阿片类药物过量表达了对纳洛酮自动售货机的渴望,但被确定
建筑环境(包括安全性和位置)的特征是有助于使用的感知因素。那里
在美国,对纳洛酮自动售货机的普遍兴趣,实施挑战已放缓
下降或有限的采用率,包括浏览利益相关者批准并确定适当的位置
放置。该提案的目的是研究社区发起的,利益相关者的适应
纳洛酮分布,您的社区(Vendy)的自动售货机纳洛酮分布,以增加
在服务不足的人群中,阿片类药物过量的纳洛酮范围。研究目的包括:
目的1:使用一个服务的3个服务不足的社区(2个城市和1个农村)的vendy计划
迭代用户以用户为中心的设计(UCD)实施策略和利益相关者参与,以增加
覆盖,实施和可持续性。我们将使用迭代可用性和消息测试来完善
与滥用阿片类药物的社区成员进行计划。我们将进行调查和定性访谈
利益相关者可以完善UCD实施策略,以供将来使用。
目标2:对2个城市和1个农村社区的Vendy计划进行6个月的试点评估。
飞行员包括中期适应和评估覆盖范围,有效性,采用,实施
和维护(re-aim)结果。
目标3:确定社会和建筑环境中的因素,促进和实施
Vendy计划使用组织实施者和社区的Photovoice定性评估
成员当前使用阿片类药物。光盘评估将在AIM 1的潜在位置进行,以告知
Vendy安置和AIM 2的Vendy位置,以告知利益相关者的适应。
诸如Vendy之类的社区方法对于与当前尚未达到阿片类药物的用户尤为重要
参与卫生系统。为了实现这些目标,瓦格纳博士将在1)以用户为中心进行培训
设计,创新的实施策略,2)在不同环境中进行务实试验的行为,3)
评估建筑和社会环境及其对覆盖范围和实施的影响。这是指导的
研究项目和职业发展计划旨在为瓦格纳博士做好准备,成为成为领导者
适应有效干预措施,以解决药物使用,以更好地达到服务不足的人群和
生产可持续的实施模型。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nicole Marie Wagner其他文献
Nicole Marie Wagner的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Nicole Marie Wagner', 18)}}的其他基金
Vending machine Naloxone Distribution for Your community (VENDY): Increasing reach and implementation of naloxone distribution
社区自动售货机纳洛酮配送 (VENDY):扩大纳洛酮配送的覆盖范围和实施
- 批准号:
10506767 - 财政年份:2022
- 资助金额:
$ 14.73万 - 项目类别:
相似国自然基金
采用新型视觉-电刺激配对范式长期、特异性改变成年期动物视觉系统功能可塑性
- 批准号:32371047
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
破解老年人数字鸿沟:老年人采用数字技术的决策过程、客观障碍和应对策略
- 批准号:72303205
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
通过抑制流体运动和采用双能谱方法来改进烧蚀速率测量的研究
- 批准号:12305261
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
采用多种稀疏自注意力机制的Transformer隧道衬砌裂缝检测方法研究
- 批准号:62301339
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
政策激励、信息传递与农户屋顶光伏技术采用提升机制研究
- 批准号:72304103
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Integrating Tailored Postoperative Opioid Tapering and Pain Management Support for Patients on Long-Term Opioid Use Presenting for Spine Surgery (MIRHIQL)
为脊柱手术中长期使用阿片类药物的患者整合定制的术后阿片类药物逐渐减量和疼痛管理支持 (MIRHIQL)
- 批准号:
10722943 - 财政年份:2023
- 资助金额:
$ 14.73万 - 项目类别:
Screening and Brief Intervention for Prescription Stimulant Misuse and Diversion: Refining and Piloting a Curriculum for College Health Providers
针对处方兴奋剂滥用和转移的筛查和简短干预:为大学医疗服务提供者完善和试点课程
- 批准号:
10731122 - 财政年份:2023
- 资助金额:
$ 14.73万 - 项目类别:
Addressing Gaps in Language Access Services through a Patient-Centered Decision-Support Tool
通过以患者为中心的决策支持工具解决语言获取服务中的差距
- 批准号:
10699030 - 财政年份:2023
- 资助金额:
$ 14.73万 - 项目类别:
Augmenting Pharmacogenetics with Multi-Omics Data and Techniques to Predict Adverse Drug Reactions to NSAIDs
利用多组学数据和技术增强药物遗传学,预测 NSAID 的药物不良反应
- 批准号:
10748642 - 财政年份:2023
- 资助金额:
$ 14.73万 - 项目类别:
Dissemination and implementation of DIGEST™ as an evidence-based measurement tool for dysphagia in cancer
传播和实施 DIGEST™ 作为癌症吞咽困难的循证测量工具
- 批准号:
10584824 - 财政年份:2023
- 资助金额:
$ 14.73万 - 项目类别: